ストックスクリーナーアプリを入手
0.3618
0.47%
0.0017
アフターアワーズ：
.36
-0.0018
-0.50%
前日終値:
$0.3601
開ける：
$0.362
24時間の取引高:
41,587
Relative Volume:
0.16
時価総額：
$8.40M
収益：
$81.89M
当期純損益:
$-55.20M
株価収益率:
-0.1342
EPS:
-2.6959
ネットキャッシュフロー:
$-67.40M
1週間 パフォーマンス:
+8.88%
1か月 パフォーマンス:
+4.51%
6か月 パフォーマンス:
-31.74%
1年 パフォーマンス:
-83.92%
1日の値動き範囲:
$0.3602
$0.365
1週間の範囲:
$0.3451
$0.3774
52週間の値動き範囲:
$0.29
$2.69
Turnstone Biologics Corp Stock (TSBX) Company Profile
名前
Turnstone Biologics Corp
セクター
電話
347-897-5988
住所
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
TSBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TSBX
Turnstone Biologics Corp
|
0.3618 | 8.40M | 81.89M | -55.20M | -67.40M | -2.6959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-05 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-11-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-10-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-08-16 | 開始されました | SVB Securities | Market Perform |
| 2023-08-15 | 開始されました | BofA Securities | Buy |
| 2023-08-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Turnstone Biologics Corp (TSBX) 最新ニュース
Millennium Management LLC Cuts Position in Turnstone Biologics Corp. (NASDAQ:TSBX) - Defense World
Atara Biotherapeutics (NASDAQ:ATRA) & Turnstone Biologics (NASDAQ:TSBX) Financial Analysis - Defense World
Check out Turnstone Biologics Corp's stock price (TSBX) in real time - CNBC
Turnstone Biologics Reports Q1 Loss Amid Strategic Shift - TipRanks
Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights - The Manila Times
Turnstone Biologics Reports Q1 2025 Financial Results and Updates on Strategic Alternatives - Nasdaq
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent - Bluefield Daily Telegraph
Turnstone Biologics (NASDAQ:TSBX) Shares Up 0.8% – Still a Buy? - Defense World
Turnstone Biologics stock plunges to 52-week low of $0.29 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.29 - Investing.com Australia
Turnstone Biologics stock plunges to 52-week low of $0.33 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.33 - Investing.com
Turnstone Biologics stock plunges to 52-week low of $0.34 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.34 - Investing.com
Q1 EPS Forecast for Turnstone Biologics Decreased by Analyst - Defense World
Analysts Set Expectations for TSBX Q1 Earnings - Defense World
Turnstone Biologics Corp: Strategic Partnerships and Financial Position Justify Hold Rating - TipRanks
Turnstone Biologics Reports 2024 Financial Results - TipRanks
Turnstone Biologics moves to Nasdaq Capital Market By Investing.com - Investing.com South Africa
Turnstone Biologics moves to Nasdaq Capital Market - Investing.com
Turnstone Biologics Corp. SEC 10-K Report - TradingView
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Turnstone Biologics Cuts Losses by $3.6M as Company Pivots Strategy - Stock Titan
Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Significant Growth in Short Interest - Defense World
Turnstone Biologics (TSBX) Expected to Announce Earnings on Thursday - Defense World
Turnstone Biologics stock plunges to 52-week low of $0.35 By Investing.com - Investing.com Australia
Turnstone Biologics stock plunges to 52-week low of $0.35 - Investing.com India
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering, Business Wires News - AsiaOne
Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Large Drop in Short Interest - Defense World
Turnstone Biologics Stock Hits 52-Week Low at $0.36 Amid Challenges - Investing.com Australia
Turnstone Biologics halts TIDAL-01 development, seeks alternatives - MSN
Turnstone Biologics stock plunges to 52-week low of $0.4 - MSN
Turnstone Biologics stock plunges to 52-week low of $0.4 By Investing.com - Investing.com Canada
Cautious Hold on Turnstone Biologics Amid TIL Therapy Challenges and Strategic Alternatives - TipRanks
Analysts Offer Predictions for TSBX FY2024 Earnings - Defense World
Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Turnstone Biologics Corp (TSBX) 財務データ
収益
当期純利益
現金流量
EPS
0.68%
0.50%
大文字化:
|
ボリューム (24 時間):